Michael P. Silvon
Direktor/Vorstandsmitglied bei Chronic Airway Therapeutics
Profil
Michael P.
Silvon is currently a Director at Chronic Airway Therapeutics.
Previously, he held the position of Vice President-Planning & Development at Inotiv, Inc. He was also the General Manager at BAS Evansville, Inc. from 2000 to 2002.
Additionally, he served as Vice President-Sales & Marketing at Hi-Port, Inc. and as Regional Business Manager-Americas-Fine Chemicals at Zeneca, Inc. Silvon received his undergraduate degree from Loyola University of Chicago, his MBA from Sacred Heart University, Inc., and his doctorate from the University of Vermont.
Aktive Positionen von Michael P. Silvon
| Unternehmen | Position | Beginn |
|---|---|---|
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael P. Silvon
| Unternehmen | Position | Ende |
|---|---|---|
| BAS Evansville, Inc. | Corporate Officer/Principal | 01.01.2002 |
| Zeneca, Inc. | Corporate Officer/Principal | - |
| Hi-Port, Inc. | Vertrieb & Marketing | - |
| INOTIV, INC. | Corporate Officer/Principal | - |
Ausbildung von Michael P. Silvon
| Loyola University of Chicago | Undergraduate Degree |
| Sacred Heart University, Inc. | Masters Business Admin |
| University of Vermont | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INOTIV, INC. | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
| BAS Evansville, Inc. | |
| Hi-Port, Inc. | |
| Zeneca, Inc. | |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | Health Technology |
